Boland, Michael V.

Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

Cai, C. X., Hribar, M., Baxter, S., Goetz, K., Swaminathan, S. S., Flowers, A., Brown, E. N., Toy, B., Xu, B., Chen, J., et al. (2025) · JAMA Ophthalmology

Diabetes Treatment and ManagementDrug-Induced Ocular Toxicity

Cited by 129

Advancing Toward a Common Data Model in Ophthalmology

Cai, C. X., Halfpenny, W., Boland, M. V., Lehmann, H. P., Hribar, M., Goetz, K. E., & Baxter, S. L. (2023) · Ophthalmology Science

Electronic Health Records SystemsMedical Coding and Health Information

Cited by 24

Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab

Cai, C. X., Nishimura, A., Bowring, M. G., Westlund, E., Tran, D., Ng, J. H., Nagy, P., Cook, M., McLeggon, J.-A., DuVall, S. L., et al. (2024) · Ophthalmology Retina

Retinal Diseases and TreatmentsDrug-Induced Ocular Toxicity

Cited by 20

Resident and program characteristics that impact performance on the Ophthalmic Knowledge Assessment Program (OKAP)

Zafar, S., Wang, X., Srikumaran, D., Sikder, S., Ramulu, P., Boland, M. V., Singman, E., & Woreta, F. A. (2019) · BMC Medical Education

Ophthalmology and Visual Health ResearchInnovations in Medical Education

Cited by 13